comparemela.com

Page 5 - Jon Weidanz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Boehringer acquires Abexxa Biologics to develop novel cancer therapies

Boehringer acquires Abexxa Biologics to develop novel cancer therapies
pharmaceutical-business-review.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaceutical-business-review.com Daily Mail and Mail on Sunday newspapers.

Boehringer Ingelheim Acquires Abexxa Biologics to Further Expand its Research Efforts in Cancer Immunology and Novel Immunotherapeutic Approaches

Boehringer Ingelheim Acquires Abexxa Biologics to Further Expand its Research Efforts in Cancer Immunology and Novel Immunotherapeutic Approaches
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

The gold standard for clinical diagnostic labs

Anajane Smith, clinical laboratory manager The clinical laboratory at The University of Texas at Arlington’s North Texas Genome Center has received accreditation from the College of American Pathologists (CAP), the world’s largest organization of board-certified pathologists and a leading provider of laboratory accreditation and proficiency testing programs. In collaboration with the Texas Genomics Alliance and UT Southwestern, the North Texas Genome Center offers high-speed and low-cost library preparation, sequencing and bioinformatic services to enhance the biotechnology and biomedical research communities. The accreditation certifies the laboratory’s capacity to conduct high-quality research and testing on human specimens for health assessments or to diagnose, prevent or treat disease.

The gold standard for clinical diagnostic labs - News Center - The University of Texas at Arlington

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.